• Be the ideal partner offering a flexible approach to partnerships and collaborations.
  • Be the preferred partner for CNS companies seeking expertise and full dedication on three sectors of Brain Disorders
    • Psychiatry
    • Neurology
    • Anaesthesiology/Pain
    • Rare (Orphan) Diseases
  • Brain Therapeutics’ objectives are:
    • Strategic in-licensing of innovative CNS products
    • Successful commercialization of innovative CNS products in Greece and 12 other European countries
    • Operational excellence and building of win win business model